Approach to optic neuropathies: Clinical update

Neurologist

Volumn 16, Issue 1, 2010, Pages 23-34

  Prasad, Sashank ^b   Volpe, Nicholas J ^a   Balcer, Laura J ^a  

^a Division of Neuro Ophthalmology   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Clinical examination; Clinical history; Optic neuropathy; Visual loss

Indexed keywords

ACETAZOLAMIDE; BETA1A INTERFERON; CORTICOSTEROID DERIVATIVE; GLATIRAMER; INTERFERON BETA SERINE;

BRAIN PSEUDOTUMOR; CLINICAL FEATURE; COLOR VISION; DIFFERENTIAL DIAGNOSIS; EVOKED VISUAL RESPONSE; GIANT CELL ARTERITIS; HUMAN; INTRACRANIAL HYPERTENSION; ISCHEMIC OPTIC NEUROPATHY; LEBER HEREDITARY OPTIC NEUROPATHY; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE DISEASE; OPTIC NERVE TUMOR; OPTIC NEURITIS; OPTICAL COHERENCE TOMOGRAPHY; PAPILLEDEMA; PRIORITY JOURNAL; RETINA ISCHEMIA; REVIEW; VISUAL ACUITY; VISUAL FIELD; VISUAL IMPAIRMENT;

DIAGNOSIS, DIFFERENTIAL; EYE; FUNCTIONAL LATERALITY; HUMANS; NEUROLOGIC EXAMINATION; OPTIC NERVE DISEASES; VISION DISORDERS;

EID: 75749087688     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/NRL.0b013e3181be6fad     Document Type: Review

References (41)

1. Frisen L. The neurology of visual acuity. Brain. 1980;103:639-670.
2. Kniestedt C, Stamper RL. Visual acuity and its measurement. Ophthalmol Clin North Am. 2003;16:155-170, v.
3. Baier ML, Cutter GR, Rudick RA, et al. Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis. Neurology. 2005;64:992-995.
4. Balcer LJ, Baier ML, Pelak VS, et al. New low-contrast vision charts: reliability and test characteristics in patients with multiple sclerosis. Mult Scler. 2000;6:163-171.
5. Melamud A, Hagstrom S, Traboulsi E. Color vision testing. Ophthalmic Genet. 2004;25:159-187.
6. Lanthony P. Color vision defects in optic neuropathies. Clinical forms. Ophtalmologie. 1987;1:27-30.
7. Levatin P. Pupillary escape in disease of the retina or optic nerve. Arch Ophthalmol. 1959;62:768-779.
8. Bremner FD. Pupil assessment in optic nerve disorders. Eye. 2004;18:1175-1181.
9. Jonas JB, Budde WM, Panda-Jonas S. Ophthalmoscopic evaluation of the optic nerve head. Surv Ophthalmol. 1999;43:293-320.
10. Prasad S, Balcer LJ. Abnormalities of the optic nerve and retina. In: Bradley WG, Daroff RB, Fenichel GM, et al, eds. Neurology in Clinical Practice, 5th ed. Philadelphia, PA: Elsevier; 2008:183-196.
11. Group ONS. The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol. 1991;109:1673-1678.
12. Balcer LJ. Clinical practice. Optic neuritis. N Engl J Med. 2006;354:1273-1280.
13. Group ONS. Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial. Ophthalmology. 2008;115: 1079-1082, e1075.
14. Volpe NJ. The optic neuritis treatment trial: a definitive answer and profound impact with unexpected results. Arch Ophthalmol. 2008;126:996-999.
15. Jacobs LD, Beck RW, Simon JH; CHAMPS Study Group. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med. 2000;343:898-904.
16. Kappos L, Weinshenker B, Pozzilli C, et al. Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials. Neurology. 2004;63: 1779-1787.
17. Frohman E, Costello F, Zivadinov R, et al. Optical coherence tomography in multiple sclerosis. Lancet Neurol. 2006;5:853-863.
18. Frohman EM, Costello F, Stuve O, et al. Modeling axonal degeneration within the anterior visual system: implications for demonstrating neuroprotection in multiple sclerosis. Arch Neurol. 2008;65:26-35.
19. Jarius S, Paul F, Franciotta D, et al. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol. 2008;4:202-214.
20. Jacob A, Weinshenker BG, Violich I, et al. Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Arch Neurol. 2008;65: 1443-1448.
21. Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet. 2008;372:234-245.
22. Fontal MR, Kerrison JB, Garcia R, et al. Ischemic optic neuropathy. Semin Neurol. 2007;27:221-232.
23. Rizzo JF III, Lessell S. Optic neuritis and ischemic optic neuropathy. Overlapping clinical profiles. Arch Ophthalmol. 1991;109:1668-1672.
24. Hayreh SS, Zimmerman MB. Nonarteritic anterior ischemic optic neuropathy: natural history of visual outcome. Ophthalmology. 2008;115:298-305, e292.
25. Hayreh SS, Zimmerman MB. Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol. 2008;246:1029-1046.
26. Hayreh SS, Zimmerman MB. Incipient nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2007;114:1763-1772.
27. Hayreh SS. Posterior ischaemic optic neuropathy: clinical features, pathogenesis, and management. Eye. 2004;18:1188-1206.
28. Prasad S, Moss HE, Lee EB, et al. Clinical reasoning: a 42-year-old man with sequential monocular visual loss. Neurology. 2008;71:e43-e49.
29. March GA Jr, Lessell S. Infectious optic neuropathy. Int Ophthalmol Clin. 1996;36:197-205.
30. Listernick R, Ferner RE, Liu GT, et al. Optic pathway gliomas in neurofibromatosis- 1: controversies and recommendations. Ann Neurol. 2007;61: 189-198.
31. Spoor TC, Kennerdell JS, Martinez AJ, et al. Malignant gliomas of the optic nerve pathways. Am J Ophthalmol. 1980;89:284-292.
32. Danesh-Meyer HV. Radiation-induced optic neuropathy. J Clin Neurosci. 2008;15:95-100.
33. Damek DM. Paraneoplastic Retinopathy/Optic Neuropathy. Curr Treat Options Neurol. 2005;7:57-67.
34. Man PY, Turnbull DM, Chinnery PF. Leber hereditary optic neuropathy. J Med Genet. 2002;39:162-169.
35. Newman NJ. Hereditary optic neuropathies: from the mitochondria to the optic nerve. Am J Ophthalmol. 2005;140:517-523.
36. Jonas JB, Budde WM. Diagnosis and pathogenesis of glaucomatous optic neuropathy: morphological aspects. Prog Retin Eye Res. 2000;19:1-40.
37. Anderson DR, Drance SM, Schulzer M. Natural history of normal-tension glaucoma. Ophthalmology. 2001;108:247-253.
38. Sarkies N. Traumatic optic neuropathy. Eye. 2004;18:1122-1125.
39. Yu Wai Man P, Griffiths PG. Surgery for traumatic optic neuropathy. Cochrane Database Syst Rev. 2005:CD005024.
40. Yu-Wai-Man P, Griffiths PG. Steroids for traumatic optic neuropathy. Cochrane Database Syst Rev. 2007:CD006032.
41. Daniels AB, Liu GT, Volpe NJ, et al. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol. 2007;143:635-641.